Baxter Aktiengesellschaft

Facc Ag

Other

Baxter International Inc.

Walter Fuerst

Heinz Redl

Rudolf Kneidinger

Douglas L Looker

Sam L Helgerson

Jane P Richards

Elisabeth M Inman

Catalina Wong

Guenter Nelboeck

Andreas Hoellrigl

Konstantin Horejsi

Ernst Haugeneder

Boris Stubna

Andreas Wuertinger

The invention relates to a casing for an aircraft engine, in particular a bypass pipe or fan casing, consisting of a plurality of hardened prepreg plies in which the fibers are oriented differently, and to a method for producing a casing of said type. In order to improve the resistance properties of the casing, especially in fire resistance tests, and reduce the amount of wasted prepreg material, at least one reinforcement ply is provided that consists of a prepreg strip having several windings, and the prepreg strip of each reinforcement ply includes a lateral overlapping portion.

Casing for an aircraft engine and method for producing a casing of said type

The invention relates to a fan case for an aircraft engine in the region of the fan thereof, comprising a plurality of substantially cylindrically arranged fiber-reinforced plastic layers that are joined together, wherein a reinforcement ply made of a glass fiber-reinforced plastic is disposed between an inner layer and an outer layer. According to the invention, the reinforcement ply consists of at least 20 plies of a glass fiber-reinforced plastic, and that deformation layers are disposed on both sides of the reinforcement ply, which deformation layers have a lower strength than the reinforcement ply.

Fan case for an aircraft engine

A fibrin/fibrinogen binding conjugate for forming a depot for the sustained release of a pharmaceutically active substance from a fibrin clot. The conjugate comprises a fibrin/fibrinogen binding moiety bound to a pharmaceutically active substance either directly or via an intervening substance capturing moiety such as an antibody. The conjugate can also be a recombinant fusion protein comprising a fibrin/fibrinogen binding moiety such as VEGFC-terminal domain fused to a wound-healing substance such as leptin.

Fibrin/fibrinogen-binding conjugate

A fibrin/fibrinogen binding conjugate for forming a depot for the sustained release of a pharmaceutically active substance from a fibrin clot. The conjugate comprises a fibrin/fibrinogen binding moiety bound to a pharmaceutically active substance either directly or via an intervening substance capturing moiety such as an antibody. The conjugate can also be a recombinant fusion protein comprising a fibrin/fibrinogen binding moiety such as VEGF C-terminal domain fused to a wound-healing substance such as leptin.

Fibrin/fibrinogen binding conjugate

Growing community of inventors

Vienna, Austria

Walter Fuerst